Cargando…

Life expectancy difference and life expectancy ratio: two measures of treatment effects in randomised trials with non-proportional hazards

The hazard ratio (HR) is the most common measure of treatment effect in clinical trials that use time-to-event outcomes such as survival. When survival curves cross over or separate only after a considerable time, the proportional hazards assumption of the Cox model is violated, and HR can be mislea...

Descripción completa

Detalles Bibliográficos
Autores principales: Dehbi, Hakim-Moulay, Royston, Patrick, Hackshaw, Allan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group Ltd. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5444092/
https://www.ncbi.nlm.nih.gov/pubmed/28546261
http://dx.doi.org/10.1136/bmj.j2250
_version_ 1783238671961423872
author Dehbi, Hakim-Moulay
Royston, Patrick
Hackshaw, Allan
author_facet Dehbi, Hakim-Moulay
Royston, Patrick
Hackshaw, Allan
author_sort Dehbi, Hakim-Moulay
collection PubMed
description The hazard ratio (HR) is the most common measure of treatment effect in clinical trials that use time-to-event outcomes such as survival. When survival curves cross over or separate only after a considerable time, the proportional hazards assumption of the Cox model is violated, and HR can be misleading. We present two measures of treatment effects for situations where the HR changes over time: the life expectancy difference (LED) and life expectancy ratio (LER). LED is the difference between mean survival times in the intervention and control arms. LER is the ratio of these two times. LED and LER can be calculated for at least two time intervals during the trial, allowing for curves where the treatment effect changes over time. The two measures are readily interpretable as absolute and relative gains or losses in life expectancy.
format Online
Article
Text
id pubmed-5444092
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BMJ Publishing Group Ltd.
record_format MEDLINE/PubMed
spelling pubmed-54440922017-05-26 Life expectancy difference and life expectancy ratio: two measures of treatment effects in randomised trials with non-proportional hazards Dehbi, Hakim-Moulay Royston, Patrick Hackshaw, Allan BMJ Research Methods & Reporting The hazard ratio (HR) is the most common measure of treatment effect in clinical trials that use time-to-event outcomes such as survival. When survival curves cross over or separate only after a considerable time, the proportional hazards assumption of the Cox model is violated, and HR can be misleading. We present two measures of treatment effects for situations where the HR changes over time: the life expectancy difference (LED) and life expectancy ratio (LER). LED is the difference between mean survival times in the intervention and control arms. LER is the ratio of these two times. LED and LER can be calculated for at least two time intervals during the trial, allowing for curves where the treatment effect changes over time. The two measures are readily interpretable as absolute and relative gains or losses in life expectancy. BMJ Publishing Group Ltd. 2017-05-25 /pmc/articles/PMC5444092/ /pubmed/28546261 http://dx.doi.org/10.1136/bmj.j2250 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/.
spellingShingle Research Methods & Reporting
Dehbi, Hakim-Moulay
Royston, Patrick
Hackshaw, Allan
Life expectancy difference and life expectancy ratio: two measures of treatment effects in randomised trials with non-proportional hazards
title Life expectancy difference and life expectancy ratio: two measures of treatment effects in randomised trials with non-proportional hazards
title_full Life expectancy difference and life expectancy ratio: two measures of treatment effects in randomised trials with non-proportional hazards
title_fullStr Life expectancy difference and life expectancy ratio: two measures of treatment effects in randomised trials with non-proportional hazards
title_full_unstemmed Life expectancy difference and life expectancy ratio: two measures of treatment effects in randomised trials with non-proportional hazards
title_short Life expectancy difference and life expectancy ratio: two measures of treatment effects in randomised trials with non-proportional hazards
title_sort life expectancy difference and life expectancy ratio: two measures of treatment effects in randomised trials with non-proportional hazards
topic Research Methods & Reporting
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5444092/
https://www.ncbi.nlm.nih.gov/pubmed/28546261
http://dx.doi.org/10.1136/bmj.j2250
work_keys_str_mv AT dehbihakimmoulay lifeexpectancydifferenceandlifeexpectancyratiotwomeasuresoftreatmenteffectsinrandomisedtrialswithnonproportionalhazards
AT roystonpatrick lifeexpectancydifferenceandlifeexpectancyratiotwomeasuresoftreatmenteffectsinrandomisedtrialswithnonproportionalhazards
AT hackshawallan lifeexpectancydifferenceandlifeexpectancyratiotwomeasuresoftreatmenteffectsinrandomisedtrialswithnonproportionalhazards